Free Trial
NASDAQ:TECX

Tectonic Therapeutic 11/9/2023 Earnings Report

Tectonic Therapeutic logo
$24.08 +0.38 (+1.60%)
Closing price 04:00 PM Eastern
Extended Trading
$24.10 +0.02 (+0.06%)
As of 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tectonic Therapeutic EPS Results

Actual EPS
-$0.44
Consensus EPS
-$0.23
Beat/Miss
Missed by -$0.21
One Year Ago EPS
N/A

Tectonic Therapeutic Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tectonic Therapeutic Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Tectonic Therapeutic's Q3 2025 earnings is scheduled for Thursday, November 6, 2025, with a conference call scheduled on Wednesday, November 5, 2025 at 6:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Tectonic Therapeutic Earnings Headlines

Tectonic Therapeutic Reports Q2 Financial Results
Tectonic (TECX) Q2 R&D Soars 142%
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel
See More Tectonic Therapeutic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tectonic Therapeutic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tectonic Therapeutic and other key companies, straight to your email.

About Tectonic Therapeutic

Tectonic Therapeutic (NASDAQ:TECX) engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.

View Tectonic Therapeutic Profile

More Earnings Resources from MarketBeat